Comparison of Visceral Leishmaniasis Diagnostic Antigens in African and Asian Leishmania donovani Reveals Extensive Diversity and Region-specific Polymorphisms

PLoS Neglected Tropical Diseases

Volumn 7, Issue 2, 2013, Pages

  Bhattacharyya, Tapan ^a   Boelaert, Marleen ^b   Miles, Michael A ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

KINESIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; COMPARATIVE STUDY; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; VISCERAL LEISHMANIASIS;

EID: 84874760945     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002057     Document Type: Article

References (31)

1. WHO (2010). First WHO report on neglected tropical diseases: Working to overcome the global impact of neglected tropical diseases. WHO, Geneva. http://www.who.int/neglected_diseases/2010report/en/index.html.
2. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, et al. (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7: e35671.
3. Kuhls K, Alam MZ, Cupolillo E, Ferreira GEM, Mauricio IL, et al. (2011) Comparative microsatellite typing of New World Leishmania infantum reveals low heterogeneity among populations and its recent Old World origin. PLoS Negl Trop Dis 5: e1155 doi:10.1371/journal.pntd.0001155.
4. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, et al. (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5: 873-882.
5. Srivastava P, Dayama A, Mehrotra S, Sundar S, (2011) Diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg 105: 1-6.
6. WHO (2010). WHO Technical Report Series 949. Control of the Leishmaniases. WHO, Geneva. http://apps.who.int/iris/bitstream/10665/44412/1/WHO_TRS_949_eng.pdf.
7. Burns JM, Shreffler WG, Benson DR, Ghalib HW, Badaro R, et al. (1993) Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci USA 90: 775-779.
8. Boelaert M, El-Safi S, Hailu A, Mukhtar M, Rijal S, et al. (2008) Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent. Trans R Soc Trop Med Hyg 102: 32-40.
9. Cunningham J, Hasker E, Das P, El Safi S, Goto H, et al. (2012) A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis. Clin Infect Dis 55: 1312-1319.
10. Sivakumar R, Sharma P, Chang K-P, Singh S, (2006) Cloning, expression, and purification of a novel recombinant antigen from Leishmania donovani. Protein Expr Purif 46: 156-165.
11. Dey A, Sharma U, Singh S, (2007) First case of indigenous visceral leishmaniasis from central India. Am J Trop Med Hyg 77: 95-8.
12. Takagi H, Islam MZ, Itoh M, Islam AU, Saifuddin Ekram AR, et al. (2007) Production of recombinant kinesin-related protein of Leishmania donovani and its application in the serodiagnosis of visceral leishmaniasis. Am J Trop Med Hyg 76: 902-5.
13. Gerald NJ, Coppens I, Dwyer DN, (2007) Molecular dissection and expression of the LdK39 kinesin in the human pathogen, Leishmania donovani. Mol Microbiol 63: 962-979.
14. Alce TM, Gokool S, McGhie D, Stager S, Smith DF, (1999) Expression of hydrophilic surface proteins in infective stages of Leishmania donovani. Mol Biochem Parasitol 102: 191-196.
15. Pattabhi S, Whittle J, Mohamath R, El-Safi S, Moulton GG, et al. (2010) Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis. PLoS Negl Trop Dis 4: e822 doi:10.1371/journal.pntd.0000822.
16. Vaish M, Bhatia A, Reed SG, Chakravarty J, Sundar S, (2012) Evaluation of rK28 antigen for serodiagnosis of visceral Leishmaniasis in India. Clin Microbiol Infect 18: 81-85.
17. Bhatia A, Daifalla NS, Jen S, Badaro R, Reed SG, et al. (1999) Cloning, characterization and serological evaluation of K9 and K26: two related hydrophilic antigens of Leishmania chagasi. Mol Biochem Parasitol 102: 249-261.
18. Peacock CS, Seeger K, Harris D, Murphy L, Ruiz JC, et al. (2007) Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet 39: 839-847.
19. Downing T, Imamura H, Decuypere S, Clark TG, Coombs GH, et al. (2011) Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res 21: 2143-2156.
20. Hall TA, (1999) Bioedit: a user friendly biological sequence alignment edit and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41: 95-98.
21. Lukeš J, Mauricio IL, Schönian G, Dujardin JC, Soteriadou K, et al. (2007) Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy. Proc Natl Acad Sci USA 104: 9375-9380.
22. Kuhls K, Keilonat L, Ochsenreither S, Schaar M, Schweynoch C, et al. (2007) Multilocus microsatellite typing (MLMT) reveals genetically isolated populations between and within the main endemic regions of visceral leishmaniasis. Microbes Infect 9: 334-343.
23. Alam MZ, Kuhls K, Schweynoch C, Sundar S, Rijal S, et al. (2009) Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent. Infect Genet Evol 9: 24-31.
24. Costa MM, Penido M, dos Santos MS, Doro D, de Freitas E, et al. (2012) Improved Canine and Human Visceral Leishmaniasis Immunodiagnosis Using Combinations of Synthetic Peptides in Enzyme-Linked Immunosorbent Assay. PLoS Negl Trop Dis 6: e1622.
25. McKean PG, Trenholme KR, Rangarajan D, Keen JK, Smith DF, (1997) Diversity in repeat-containing surface proteins of Leishmania major. Mol Biochem Parasitol 86: 225-235.
26. Stäger S, Smith DF, Kaye PM, (2000) Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis. J Immunol 165: 7064-7071.
27. Moreno J, Nieto J, Masina S, Cañavate C, Cruz I, et al. (2007) Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis. Vaccine 25: 5290-5300.
28. Sádlová J, Price HP, Smith BA, Votýpka J, Volf P, et al. (2010) The stage-regulated HASPB and SHERP proteins are essential for differentiation of the protozoan parasite Leishmania major in its sand fly vector, Phlebotomus papatasi. Cell Microbiol 12: 1765-1779.
29. Depledge DP, MacLean LM, Hodgkinson MR, Smith BA, Jackson AP, et al. (2010) Leishmania-Specific Surface Antigens Show Sub-Genus Sequence Variation and Immune Recognition. PLoS Negl Trop Dis 4: e829.
30. Haralambous C, Antoniou M, Pratlong F, Dedet J-P, Soteriadou K, (2008) Development of a molecular assay specific for the Leishmania donovani complex that discriminates L. donovani/Leishmania infantum zymodemes: a useful tool for typing MON-1. Diagn Microbiol Infect Dis 60: 33-42.
31. Maroof A, Brown N, Smith B, Hodgkinson MR, Maxwell A, et al. (2012) Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis. J Infect Dis 205: 853-863.